Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norethindrone Acetate Pretreatment for LNG IUS Insertion
NCT01391052Phase 4Unknown
- Sponsor
- Baylor Scott & White Health
- Start
- Jan 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of norethisterone acetate in Heavy menstrual bleeding, sponsored by Baylor Scott & White Health. Status: unknown.
02
Drugs
norethisterone acetate
03
Conditions
Heavy menstrual bleeding
Beyond the preview
Go deeper on NCT01391052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01391052.